News | Maine Biotek

Maine BioTek was awarded a Phase II Small Business Innovation Research grant from the National Science Foundation for development of an Atlantic cod nodavirus recombinant vaccine and a Phase II Small Business Innovation Research grant from the National Oceanic and Atmospheric Administration for development of an Atlantic cod multivalent bacterial vaccine.